Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

OBJECTIVES: The emergence of a SARS‐CoV‐2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Immunology
Main Authors: Lee, Cheryl Yi‐Pin, Amrun, Siti Naqiah, Chee, Rhonda Sin‐Ling, Goh, Yun Shan, Mak, Tze‐Minn, Octavia, Sophie, Yeo, Nicholas Kim‐Wah, Chang, Zi Wei, Tay, Matthew Zirui, Torres‐Ruesta, Anthony, Carissimo, Guillaume, Poh, Chek Meng, Fong, Siew‐Wai, Bei, Wang, Lee, Sandy, Young, Barnaby Edward, Tan, Seow‐Yen, Leo, Yee‐Sin, Lye, David C, Lin, Raymond TP, Maurer‐Stroh, Sebastien, Lee, Bernett, Wang, Cheng‐I, Renia, Laurent, Ng, Lisa FP
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899292/
https://ncbi.nlm.nih.gov/pubmed/33628442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1241
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados